Prevalence and determinants of hyperhomocysteinemia in hemodialysis and peritoneal dialysis

Kidney International

Volumn 55, Issue 4, 1999, Pages 1470-1475

  Moustapha, Ali ^a   Gupta, Anjan ^a   Robinson, Killian ^a   Arheart, Kristopher ^a   Jacobsen, Donald W ^a   Schreiber, Martin J ^a   Dennis, Vincent W ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Dialysis; Folic acid; Homocyteine; Renal failure; Vascular disease

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; PYRIDOXAL 5 PHOSPHATE;

ADULT; ARTICLE; ATHEROSCLEROSIS; CONTROLLED STUDY; GLOMERULUS FILTRATION RATE; HEMODIALYSIS; HUMAN; HYPERHOMOCYSTEINEMIA; KIDNEY FAILURE; MAJOR CLINICAL STUDY; PERITONEAL DIALYSIS; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; VASCULAR DISEASE; VITAMIN BLOOD LEVEL;

EID: 0032941601     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.1999.00378.x     Document Type: Article

References (29)

1. CHAUVEAU P, CHADEFAUX B, COUDÉ M, AUPETIT J, HANNEDOUCHE T, KAMOUN P, JUNGERS P: Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients. Kidney Int 41 (Suppl):S72-S77, 1993
2. BACHMANN J, TEPEL M, RAIDT H, RIEZLER R, GRAEFE U, LANGER K, ZIDEK W: Hyperhomocysteinemia and the risk for vascular disease in hemodialysis patients. J Am Soc Nephral 6:121-125, 1995
3. DENNIS VW, NURKO S, ROBINSON K: Hyperhomocysteinemia: Detection, risk assessment, and treatment. Curr Opin Nephrol Hypertens 6:483-488, 1997
4. KIM SS, HIROSE S, TAMURA H, NAGASAWA R, TOKUSHIMA H, MITARAI T, ISODA K: Hyperhomocysteinemia as a possible role for atherosclerosis in CAPD patients. Adv Perit Dial 10:282-285, 1994
5. ROBINSON K, GUPTA A, DENNIS VW, ARHEART K, CHAUDHARY D, GREEN R, VIGO P, MAYER EL, SELHUB J, KUTNER M, JACOBSEN DW: Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations. Circulation 94:2743-2748, 1996
6. MOUSTAPHA A, NASO A, NAHLAWI M, GUPTA A, ARHEART KL, JACOBSEN DW, ROBINSON K, DENNIS VW: Prospective study of hyperhomocysteinemia as an adverse cardiovascular risk factor in end-stage renal disease. Circulation 97:138-141, 1998
7. BOSTOM AG, LATHROP L: Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes. Kidney Int 52:10-20, 1997
8. ARNADOTTIR M, BRATTSTRÖM L, SIMONSEN O, THYSELL H, HULTBERG B, ANDERSSON A, NILSSON-EHLE P: The effect of high-dose pyridoxine and folic acid supplementation on serum lipid and plasma homocysteine concentrations in dialysis patients. Clin Nephrol 40:236-240, 1993
9. WILCKEN DEL, DUDMAN NPB, TYRRELL PA, ROBERTSON MR: Folic acid lowers elevated plasma homocysteine in chronic renal insufficiency: Possible implications for prevention of vascular disease. Metabolism 37:697-701, 1988
10. BOSTOM AG, SHEMIN D, LAPANE KL, MILLER JW, SUTHERLAND P, NADEAU M, SEYOUM E, HARTMAN W, PRIOR R, WILSON PWF, SELHUB J: Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: A case-control study. Atherosclerosis 114:93-103, 1995
11. BOSTOM A, BROSNAN JT, HALL B, NADEAU MR, SELHUB J: Net uptake of plasma homocysteine by the rat kidney in vivo. Atherosclerosis 116:59-62, 1995
12. JACOBSEN DW, GATAUTIS VJ, GREEN R, ROBINSON K, SAVON SR, SECIC M, JI J, OTTO JM, TAYLOR LM JR: Rapid HPLC determination of total homocysteine and other thiols in serum and plasma: Sex differences and correlation with cobalamin and folate concentrations in healthy subjects. Clin Chem 40:873-881, 1994
13. CAMP VM, CHIPPONI J, FARAJ BA: Radioenzymatic assay for direct measurement of plasma pyridoxal 5'-phosphate. Clin Chem 29: 642-644, 1983
14. BOSTOM AG, SHEMIN D, LAPANE KL, NADEAU MR, SUTHERLAND P, CHAN J, ROZEN R, YOBURN D, JACQUES PF, SELHUB J, ROSENBERG IH: Folate Status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients. Atherosclerosis 123:193-202, 1996
15. TAMURA T, JOHNSTON KE, BERGMAN SM: Homocysteine and folate concentrations in blood from patients treated with hemodialysis. J Am SOC Nephrol 7:2414-2418, 1996
16. CHAUVEAU P, CHADEFAUX B, COUDÉ M, AUPETIT J, KAMOUN P, JUNGERS P: Long-term folic acid (but not pyridoxine) supplementation lowers elevated plasma homocysteine level in chronic renal failure. Miner Electrolyte Metab 22:106-109, 1996
17. BOSTOM AG, SHEMIN D, LAPANE KL, HUME AL, YOBURN D, NADEAU MR, BENDICH A, SELHUB J, ROSENBERG IH: High dose-B-vitamin treatment of hyperhomocysteinemia in dialysis patients. Kidney Int 49:147-152, 1996
18. JANSSEN MJFM, VAN GULDENER C, DE JONG GMT, VAN DEN BERG M, STEHOUWER CDA, DONKER AJM: Folic acid treatment of hyperhomocysteinemia in dialysis patients. Miner Electrolyte Metab 22:110-114, 1996
19. JENNETTE JC, GOLDMAN ID: Inhibition of the membrane transport of folates by anions retained in uremia. J Lab Clin Med 86:834-843, 1975
20. RETIEF FP, HEYNS AP, OOSTHUIZEN M, VAN REENEN OR: Aspects of folate metabolism in renal failure. Br J Haematol 36:405-415, 1977
21. HALSTED CH: The intestinal absorption of dietary folates in health and disease. J Am Coll Nutr 8:650-658, 1989
22. HEMMELØFF ANDERSEN KE: Folic acid status of patients with chronic renal failure maintained by dialysis. Clin Nephrol 8:510-513, 1977
23. RAMIREZ G, CHEN M, BOYCE HW JR, FULLER SM, GANGULY R, BRUEGGEMEYER CD, BUTCHER DE: Longitudinal follow-up of chronic hemodialysis patients without vitamin supplementation. Kidney Int 30:99-106, 1986
24. CUNNINGHAM J, SHARMAN VL, GOODWIN FJ, MARSH FP: Do patients receiving haemodialysis need folic acid supplements? Br Med J Clin Res Educ 282:1582, 1981
25. BERGMARK C, MANSOOR MA, SWEDENBORG J, DE FAIRE U, SVARDAL AM, UELAND PM: Hyperhomocysteinemia in patients operated for lower extremity ischaemia below the age of 50: Effect of smoking and extent of disease. Eur J Vasc Surg 7:391-396, 1993
26. GODIN CS, CROOKS PA: In vivo depletion of S-adenosyl-L-homocysteine and S-adenosyl-L-methionine in guinea pig lung after chronic S-(-)-nicotine administration. Toxicol Lett 31:23-29, 1986
27. MUDD SH, POOLE JR: Labile methyl balances for normal humans on various dietary regimens. Metabolism 24:721-735, 1975
28. GUTTORMSEN AB, UELAND PM, SVARSTAD E, REFSUM H: Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure. Kidney Int 52:495-502, 1997
29. VAN GULDENER C, DONKER AJM, JAKOBS C, TEERLINK T, DE MEER K, STEHOUWER CDA: No net renal extraction of homocysteine in fasting humans. Kidney Int 54:166-169, 1998